Evidence | Lyme disease | Guidance | NICE

Evidence

Review and download supporting evidence. Includes the full guideline if available.

Supporting evidence

Evidence review
March 2018: evidence reviews
A: Awareness of Lyme disease ^{PDF 358.51 KB} 11 April 2018
B: Diagnostic accuracy of signs and symptoms ^{PDF 604.39 KB} 11 April 2018
C: Diagnostic tests ^{PDF 2.33 MB} 11 April 2018
C: Diagnostic tests – evidence tables (appendix D) ^{PDF 2.85 MB} 11 April 2018
D: Management of erythema migrans ^{PDF 4 MB} 11 April 2018
E: Management of non-specific symptoms related to Lyme disease ^{PDF 409.35 KB} 11 April 2018
F: Management of neuroborreliosis ^{PDF 736.67 KB} 11 April 2018
G: Management of Lyme arthritis ^{PDF 518.95 KB} 11 April 2018
H: Management of acrodermatitis chronica atrophicans ^{PDF 565.71 KB} 11 April 2018
I: Management of Lyme carditis ^{PDF 409.8 KB} 11 April 2018
J: Management of lymphocytoma ^{PDF 400.5 KB} 11 April 2018
K: Management of non-neurological ocular manifestations ^{PDF 405.06 KB} 11 April 2018
L: Management of ongoing symptoms related to Lyme disease ^{PDF 866.09 KB} 11 April 2018
M: Person-to-person transmission ^{PDF 415.03 KB} 11 April 2018
N: Information needs ^{PDF 424.47 KB} 11 April 2018
Other supporting evidence
Methods ^{PDF 3.27 MB} 11 April 2018
Acknowledgements ^{PDF 104.2 KB} 11 April 2018
Membership of the guideline committee ^{PDF 368 KB} 11 April 2018